目的探讨原发肝癌合并门静脉瘤栓的化学栓塞治疗。
Objective to study the clinical effectiveness of arterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis.
目的：探讨肾肿瘤并下腔静脉瘤栓诊断和治疗经验。
Purpose: To evaluate the diagnosis, treatment and prognosis of renal tumor with tumor thrombus in the inferior vena cava.
部分伴肝动脉-门静脉分流现象及门静脉和下腔静脉瘤栓形成。
Part of PHCC had arteriovenous diversion phenomenon and tumor thrombus in portal vein or cava inferior.
目的观察肾癌根治性切除加瘤栓取出术治疗肾癌合并静脉瘤栓的效果。
Objective to observe the efficacy of radical nephrectomy plus embolectomy for the treatment of renal cell carcinoma with renal vein or inferior vena cava involvement.
此研究目的为评估运用积极手术治疗伴血管瘤栓的肾细胞癌患者的临床结果和死亡率。
This study examined the clinical outcome and morbidity of patients with RCC and vascular tumor thrombus treated with aggressive surgical therapy.
目的小结肾或肾上腺肿瘤伴下腔静脉瘤栓病人的手术经验，探讨有关心血管外科技术的改进。
Objective: Primarily discuss the application of cardiac surgical technique in surgical treatment on renal or adrenal tumor with the inferior vena cava involvement.
多因素分析显示脉管瘤栓、术前ast升高、肿瘤切缘、肝被膜受侵及肿瘤最大直径依次为影响预后的主要因素。
The multivariate analysis indicated that blood vessel invasion, preoperative AST ascending, liver capsule invasion, resection margin and tumor size were the major risk factors affecting the prognosis.
结果p53、CD34在肝癌组织的表达比非癌组明显增高，且在肝癌组中伴有与不伴门脉瘤栓的两组间有统计学差别（P<0.05）。
Results The expression of P53, CD34was higher in the HCC group than in the inner group, and their expression was associated with portal vein embolus(P<0.05).
结论：溶栓疗法可降低室壁瘤的发生率，提高左室射血分数。
Conclusions: the thrombolytic therapy could decrease the incidence of va formation and enhance the value of LVEF.
儿童的淋巴管瘤死于分岔癌栓。
The child with the lymphangioma died from a bifurcation embolus.
溶栓治疗颈动脉壁间动脉瘤相关性缺血性中风的安全和功能预：个体患者数据的荟萃分析。
Safety and functional outcome of thrombolysis in dissection-related ischemic stroke: a meta-analysis of individual patient data.
目的实验研究克栓酶的抑瘤作用，以期扩展其药用范围，为治疗肿瘤增加药源。
Objective to research the Batroxobin DF 521 effect on inhibition of tumor in order to extend its useful range and provide a new drug for curing tumor.
目的实验研究克栓酶的抑瘤作用，以期扩展其药用范围，为治疗肿瘤增加药源。
Objective to research the Batroxobin DF 521 effect on inhibition of tumor in order to extend its useful range and provide a new drug for curing tumor.
应用推荐